Applying for a Barwon Health Reference Number
All applications submitted to Barwon Health for review are required to generate a reference number via the Barwon Health Research Reference Number Generator (please open with Google Chrome).
Please ensure that the Barwon Health reference number is quoted at the time of your submission.
Barwon Health participates in state and national schemes supporting the Single Ethical Review Process (SERP) for multi-site human research.
Streamlining ethical review means that an eligible multi-site research project is only required to have one ethical and scientific review conducted by a Human Research Ethics Committee (HREC), certified by the National Health and Medical Research Council (NHMRC). Each site involved with the project must conduct their own research governance authorisation before the project can commence; the Site Specific Assessment (SSA) form is used to address research governance and authorisation.
Interstate multi-site research (National Mutual Acceptance (NMA) Scheme)
The Victorian, South Australian, and Queensland Departments of Health, and the NSW Ministry of Health, have signed a Memorandum of Understanding (MOU) to introduce the National Mutual Acceptance (NMA) Scheme of ethical and scientific review of clinical trials conducted in each of the participating jurisdiction's public health organisations. Under the NMA Scheme, for organisations participating in the SERP system, a multi-site clinical trial can undergo review by one accredited reviewing HREC. Some private health services will also accept the ethical review decisions of the accredited and certified reviewing HRECs.
Victorian multi-site research
As of January 2015, the scope of the streamlined system in Victoria has been extended to include all health and medical research. The streamlined ethical and scientific review of Victorian multi-site research projects applies to any form of health and medical human research, as defined in the National Statement on Ethical Conduct in Human Research, for which an application must be made to a HREC for the purpose of conducting research at a public health organisation. This includes low and negligible risk.
A multi-site research project in Victoria will undergo a single ethical review for organisations participating in the SERP system. Victorian reviewing HRECs are certified by the NHMRC.
Accredited reviewing HRECs
The following HRECs have been accredited to provide ethical review for multi-site research projects by the Consultative Council (these HRECs are also certified by the NHMRC):
- Alfred Health
- Austin Health
- Melbourne Health
- Peter MacCallum Cancer Centre
- The Royal Children's Hospital
- Monash Health
- St Vincent's Hospital (Melbourne)
Please note: Barwon Health HREC is a participant in the NMA Scheme and the Victorian SERP as an accepting site (not a reviewing site).
Victoria's Consultative Council has responsibility for the governance of the streamlined clinical trial research initiative. Contact details for the Coordinating Office are below:
- Address - 50 Lonsdale Street, Melbourne
- Information Line - (03) 9096 7398
How to submit your multi-site application through e-submissions
What is E-Submissions?
E-submissions are direct electronic submissions for all ethics and research governance/site specific assessment (SSA) applications. An application and its supporting documents are automatically sent from the Online Forms website to the chosen reviewing ethics administrator or Research Governance Officer (RGO).
E-Submission applies to all new applications submitted to Victorian public health organisations from the Online Forms website from Friday the 19th of June 2015. This includes NEAF, SSA, LNR VIC and LNR VIC SSA applications. Please refer to the E-Submission Quick Guide for information and instructions on submitting an application from the Online Forms website. You may also find these tips on E-Submissions useful.
For assistance, please contact the Infonetica Helpdesk on (02) 9037 8404 or email firstname.lastname@example.org, or contact the Coordinating Office for Clinical Trial Research using the details outlined above.
Information on Investigator Initiated Clinical Trials
Last Modified: Tuesday, 26 February 2019